Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nobuhisa Iwata

Showing results (1-10 of 87) with videos related to

Pageof 9
Sort By:
Rinsho Shinkeigaku = Clinical Neurology|December 1, 2012
[A pathogenic mechanism of N-terminally pyroglutamylated Aβ and possible application of Alzheimer's disease by inhibition of the pyroglutamylation]Nobuhisa Iwata, Masashi Asai
Journal of Alzheimer'S Disease : JAD|September 3, 2025
The tale of donanemab: God is in the detailsTakaomi C Saido, Nobuhisa Iwata
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|July 5, 2003
[Amyloid-beta peptide metabolism and Alzheimer's disease]Nobuhisa Iwata, Takaomi C Saido
Neuroscience Research|February 7, 2006
Metabolism of amyloid beta peptide and pathogenesis of Alzheimer's disease. Towards presymptomatic diagnosis, prevention and therapyTakaomi C Saido, Nobuhisa Iwata
Journal of Biochemistry|March 25, 2017
Paradigm shift from diagnosing patients based on common symptoms to categorizing patients into subtypes with different pathogenic mechanisms to guide treatment for Alzheimer's diseaseKeiro Shirotani, Masashi Asai, Nobuhisa Iwata
Pharmacology & Therapeutics|August 23, 2005
Metabolism of amyloid-beta peptide and Alzheimer's diseaseNobuhisa Iwata, Makoto Higuchi, Takaomi C Saido
Biochimica Et Biophysica Acta|August 2, 2005
Understanding molecular mechanisms of proteolysis in Alzheimer's disease: progress toward therapeutic interventionsMakoto Higuchi, Nobuhisa Iwata, Takaomi C Saido
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 19, 2005
[Gene therapy for Alzheimer' s disease]Nobuhisa Iwata, Keiya Ozawa, Takaomi C Saido
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|July 5, 2017
Elucidating Pathogenic Mechanisms of Early-onset Alzheimer's Disease in Down Syndrome PatientsMasashi Asai, Takashi Kawakubo, Ryotaro Mori, et al.
The Journal of Biological Chemistry|April 22, 2004
Effects of neprilysin chimeric proteins targeted to subcellular compartments on amyloid beta peptide clearance in primary neuronsEmi Hama, Keiro Shirotani, Nobuhisa Iwata, et al.
Pageof 9

Showing results (1-10 of 87) with videos related to

Sort By:
Pageof 9
Rinsho Shinkeigaku = Clinical Neurology|December 1, 2012
[A pathogenic mechanism of N-terminally pyroglutamylated Aβ and possible application of Alzheimer's disease by inhibition of the pyroglutamylation]Nobuhisa Iwata, Masashi Asai
Journal of Alzheimer'S Disease : JAD|September 3, 2025
The tale of donanemab: God is in the detailsTakaomi C Saido, Nobuhisa Iwata
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|July 5, 2003
[Amyloid-beta peptide metabolism and Alzheimer's disease]Nobuhisa Iwata, Takaomi C Saido
Neuroscience Research|February 7, 2006
Metabolism of amyloid beta peptide and pathogenesis of Alzheimer's disease. Towards presymptomatic diagnosis, prevention and therapyTakaomi C Saido, Nobuhisa Iwata
Journal of Biochemistry|March 25, 2017
Paradigm shift from diagnosing patients based on common symptoms to categorizing patients into subtypes with different pathogenic mechanisms to guide treatment for Alzheimer's diseaseKeiro Shirotani, Masashi Asai, Nobuhisa Iwata
Pharmacology & Therapeutics|August 23, 2005
Metabolism of amyloid-beta peptide and Alzheimer's diseaseNobuhisa Iwata, Makoto Higuchi, Takaomi C Saido
Biochimica Et Biophysica Acta|August 2, 2005
Understanding molecular mechanisms of proteolysis in Alzheimer's disease: progress toward therapeutic interventionsMakoto Higuchi, Nobuhisa Iwata, Takaomi C Saido
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 19, 2005
[Gene therapy for Alzheimer' s disease]Nobuhisa Iwata, Keiya Ozawa, Takaomi C Saido
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|July 5, 2017
Elucidating Pathogenic Mechanisms of Early-onset Alzheimer's Disease in Down Syndrome PatientsMasashi Asai, Takashi Kawakubo, Ryotaro Mori, et al.
The Journal of Biological Chemistry|April 22, 2004
Effects of neprilysin chimeric proteins targeted to subcellular compartments on amyloid beta peptide clearance in primary neuronsEmi Hama, Keiro Shirotani, Nobuhisa Iwata, et al.
Pageof 9